z-logo
open-access-imgOpen Access
Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic
Author(s) -
Todd Logan,
Matthew Simon,
Amit Kumar Rana,
Gerald Maxwell Cherf,
Ankita Srivastava,
Sonnet S. Davis,
Ray Low,
ChiLu Chiu,
Meng Fang,
Fen Huang,
Akhil Bhalla,
Ceyda Llapashtica,
Rachel Prorok,
Michelle E. Pizzo,
Meredith Calvert,
Elizabeth W. Sun,
Jennifer HsiaoNakamoto,
Yashas Rajendra,
Katrina W. Lexa,
Devendra B. Srivastava,
Bettina van Lengerich,
Junhua Wang,
Yaneth RoblesColmenares,
Do Jin Kim,
Joseph Duque,
Melina Lenser,
Timothy Earr,
Hoang N. Nguyen,
Roni Chau,
Buyankhishig Tsogtbaatar,
Ritesh Ravi,
Lukas L. Skuja,
Hilda Solanoy,
Howard J. Rosen,
Bradley F. Boeve,
Adam L. Boxer,
Hilary W. Heuer,
Mark S. Dennis,
Mihalis S. Kariolis,
Kathryn M. Monroe,
Laralynne Przybyla,
Pascal E. Sanchez,
René Meisner,
Dolores Diaz,
Kirk R. Henne,
Ryan J. Watts,
Anastasia G. Henry,
Kannan Gunasekaran,
Giuseppe Astarita,
Jung H. Suh,
Joseph W. Lewcock,
Sarah L. DeVos,
Gilbert Di Paolo
Publication year - 2021
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2021.08.002
Subject(s) - biology , frontotemporal dementia , penetrant (biochemical) , loss function , function (biology) , frontotemporal lobar degeneration , brain function , neuroscience , neurodegeneration , microbiology and biotechnology , genetics , phenotype , dementia , medicine , gene , disease
GRN mutations cause frontotemporal dementia (GRN-FTD) due to deficiency in progranulin (PGRN), a lysosomal and secreted protein with unclear function. Here, we found that Grn -/- mice exhibit a global deficiency in bis(monoacylglycero)phosphate (BMP), an endolysosomal phospholipid we identified as a pH-dependent PGRN interactor as well as a redox-sensitive enhancer of lysosomal proteolysis and lipolysis. Grn -/- brains also showed an age-dependent, secondary storage of glucocerebrosidase substrate glucosylsphingosine. We investigated a protein replacement strategy by engineering protein transport vehicle (PTV):PGRN-a recombinant protein linking PGRN to a modified Fc domain that binds human transferrin receptor for enhanced CNS biodistribution. PTV:PGRN rescued various Grn -/- phenotypes in primary murine macrophages and human iPSC-derived microglia, including oxidative stress, lysosomal dysfunction, and endomembrane damage. Peripherally delivered PTV:PGRN corrected levels of BMP, glucosylsphingosine, and disease pathology in Grn -/- CNS, including microgliosis, lipofuscinosis, and neuronal damage. PTV:PGRN thus represents a potential biotherapeutic for GRN-FTD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom